We are live on ! Find out more
KLRS

Kalaris Therapeutics
KLRS

79 hedge funds and large institutions have $640M invested in Kalaris Therapeutics in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

66,400% more call options, than puts

Call options by funds: $1.33M | Put options by funds: $2K

28% more capital invested

Capital invested by funds: $502M → $640M (+$138M)

26% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 23

0.06% less ownership

Funds ownership: 1.77% → 1.71% (-0.06%)

6% less funds holding

Funds holding: 84 → 79 (-5)

27% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 15

Holders
79
Holders Change
-5
Holders Change %
-5.95%
% of All Funds
1.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
29
Reduced
23
Closed
15
Calls
$1.33M
Puts
$2K
Net Calls
+$1.33M
Net Calls Change
+$1.33M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$17.8M
2
GC
GMT Capital
Georgia
+$9.6M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$8.91M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$5.4M
5
SAM
Sectoral Asset Management
Quebec, Canada
+$4.6M

Top Sellers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
-$25.7M
2
RG
Redmile Group
California
-$15M
3
State Street
State Street
Massachusetts
-$9.98M
4
EC
EcoR1 Capital
California
-$8.82M
5
Lido Advisors
Lido Advisors
California
-$6.85M
Name Holding Trade Value Shares
Change 		Change in
Stake
Swiss National Bank
26
Swiss National Bank
Switzerland
$1.98M – – –
EOJOAM
27
E. Ohman J:or Asset Management
Sweden
$1.81M +$1.46M +3,148 New
AllianceBernstein
28
AllianceBernstein
Tennessee
$1.41M -$25.7M -55,552 -96%
Morgan Stanley
29
Morgan Stanley
New York
$1.36M +$159K +343 +17%
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$1.14M +$94K +203 +11%
ECM
31
Endurant Capital Management
California
$1.11M +$895K +1,932 New
UBS Group
32
UBS Group
Switzerland
$1.1M +$523K +1,129 +144%
Rafferty Asset Management
33
Rafferty Asset Management
New York
$980K -$593K -1,280 -43%
Two Sigma Investments
34
Two Sigma Investments
New York
$827K -$113K -244 -15%
Citigroup
35
Citigroup
New York
$804K -$1.62M -3,497 -71%
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$707K +$26.4K +57 +5%
Deutsche Bank
37
Deutsche Bank
Germany
$700K +$61.6K +133 +12%
UBS AM
38
UBS AM
Illinois
$680K +$277K +598 +103%
CS
39
Credit Suisse
Switzerland
$667K +$167K +361 +45%
State of Wisconsin Investment Board
40
State of Wisconsin Investment Board
Wisconsin
$634K – – –
FFN
41
Focus Financial Network
Minnesota
$630K – – –
Osaic Holdings
42
Osaic Holdings
Arizona
$625K – – –
SFI
43
Susquehanna Fundamental Investments
Pennsylvania
$597K +$480K +1,036 New
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$534K -$106K -228 -20%
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$508K -$192K -414 -32%
DekaBank Deutsche Girozentrale
46
DekaBank Deutsche Girozentrale
Germany
$473K – – –
ProShare Advisors
47
ProShare Advisors
Maryland
$443K -$33.3K -72 -9%
CSS
48
Cubist Systematic Strategies
Connecticut
$439K -$204K -441 -37%
Invesco
49
Invesco
Georgia
$410K +$38K +82 +13%
EAM
50
Erste Asset Management
Austria
$408K – – –
1
2
3 4

KLRS Hedge Fund Activity: Q3 2021 in Review

79 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Kalaris Therapeutics (KLRS) for Q3 2021, worth a combined $640M — up 28% from $502M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of KLRS and 11 opened new positions — a net loss of 4 holders — while 23 trimmed existing stakes and 29 added.

The largest buyer was Fidelity Investments, adding an estimated $17.8M. The largest seller was AllianceBernstein, cutting an estimated $25.7M.

  • 79 institutional investors held Kalaris Therapeutics (KLRS) as of Q3 2021, down from 84 in Q2 2021.
  • Funds reported $640M of Kalaris Therapeutics stock for Q3 2021, up 28% quarter-over-quarter.
  • 11 funds opened new Kalaris Therapeutics positions in Q3 2021 and 15 closed out, a net change of -4 holders.
  • The largest Kalaris Therapeutics buyer in Q3 2021 was Fidelity Investments, an estimated $17.8M added.
  • The largest Kalaris Therapeutics seller in Q3 2021 was AllianceBernstein, an estimated $25.7M sold.

Based on aggregated 13F filings for Q3 2021.